Targeting the Ischemic Penumbra

Background— In the last 3 decades, and from a therapeutic point of view, the classical concept of ischemic penumbra based on hemodynamic and electrophysiological parameters has loosened up the rigidity of therapeutic windows in acute stroke management. Thirty years later, the ischemic penumbra is an evolved concept that presents more applications. Thus, the ischemic penumbra is a diagnostic target, allowing the extension of therapeutic windows; it is also a biochemical target, in which an intermittent bioenergetic compromise takes place, and it is a target for brain plasticity, neuroprotection, and neurorepair. Summary of Review— In this work, we review how the concept of ischemic penumbra has been evolving from its purely electrophysiological/ hemodynamic based definition to the wider metabolic-cellular-therapeutic concept that is managed today by neuroscientists.

[1]  P. Weinstein,et al.  Molecular Identification of the Ischemic Penumbra , 2004, Stroke.

[2]  K. Hossmann Viability thresholds and the penumbra of focal ischemia , 1994, Annals of neurology.

[3]  K. Nicolay,et al.  A liposomal system for contrast-enhanced magnetic resonance imaging of molecular targets. , 2004, Bioconjugate chemistry.

[4]  R. McKay,et al.  Discussion point stem cells and neurogenesis in the adult brain , 1998, Current Opinion in Neurobiology.

[5]  G. Mies,et al.  Evolution of Brain Infarction after Transient Focal Cerebral Ischemia in Mice , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[6]  Fred H. Gage,et al.  The Adult Rat Hippocampus Contains Primordial Neural Stem Cells , 1997, Molecular and Cellular Neuroscience.

[7]  Deepali Mathur Proliferation in the human ipsilateral subventricular zone after ischemic stroke , 2010, Annals of Neurosciences.

[8]  T. Sobrino,et al.  Evolving Paradigms for Neuroprotection: Molecular Identification of Ischemic Penumbra , 2006, Cerebrovascular Diseases.

[9]  K. Kogure,et al.  Molecular and biochemical events within the brain subjected to cerebral ischemia (targets for therapeutical intervention). , 1997, Clinical neuroscience.

[10]  R. Koehler,et al.  In situ immunoradiographic method for quantification of specific proteins in normal and ischemic brain regions , 2005, Journal of Neuroscience Methods.

[11]  G. Vassal,et al.  Consolidation with a busulfan-containing regimen followed by stem cell transplantation in infants with poor prognosis stage 4 neuroblastoma , 2000, Bone Marrow Transplantation.

[12]  J. Hallenbeck,et al.  Neuronal regeneration after stroke. , 2003, The New England journal of medicine.

[13]  G. V. van Dam,et al.  PET/SPECT imaging: from carotid vulnerability to brain viability. , 2010, European journal of radiology.

[14]  T. Dawson,et al.  Nitric oxide synthase in models of focal ischemia. , 1997, Stroke.

[15]  M Chopp,et al.  VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. , 2000, The Journal of clinical investigation.

[16]  K. Hossmann,et al.  Periinfarct depolarizations. , 1996, Cerebrovascular and brain metabolism reviews.

[17]  R. Jain,et al.  Penumbra, the basis of neuroimaging in acute stroke treatment: Current evidence , 2010, Journal of the Neurological Sciences.

[18]  D. Hess,et al.  SDF‐1 (CXCL12) Is Upregulated in the Ischemic Penumbra Following Stroke: Association with Bone Marrow Cell Homing to Injury , 2004, Journal of neuropathology and experimental neurology.

[19]  N. Mitsios,et al.  Expression of Basic Fibroblast Growth Factor mRNA and Protein in the Human Brain following Ischaemic Stroke , 2005, Angiogenesis.

[20]  J. Saver Citicoline: update on a promising and widely available agent for neuroprotection and neurorepair. , 2008, Reviews in neurological diseases.

[21]  F. Tortella,et al.  Effects of delayed intrathecal infusion of an NMDA receptor antagonist on ischemic injury and peri-infarct depolarizations , 2005, Brain Research.

[22]  S. Pedraza,et al.  The clinical–DWI mismatch , 2004, Neurology.

[23]  C. La Rosa,et al.  Liposomes as a potential drug carrier for citicoline (CDP-choline) and the effect of formulation conditions on encapsulation efficiency. , 1992, Die Pharmazie.

[24]  N M Branston,et al.  Cortical Evoked Potential and Extracellular K+ and H+ at Critical Levels of Brain Ischemia , 1977, Stroke.

[25]  K. Hossmann Cerebral ischemia: Models, methods and outcomes , 2008, Neuropharmacology.

[26]  J. García-Verdugo,et al.  Cellular Composition and Three-Dimensional Organization of the Subventricular Germinal Zone in the Adult Mammalian Brain , 1997, The Journal of Neuroscience.

[27]  K. Jin,et al.  VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. , 2003, The Journal of clinical investigation.

[28]  J. Altman,et al.  Are New Neurons Formed in the Brains of Adult Mammals? , 1962, Science.

[29]  E. Lo,et al.  A new penumbra: transitioning from injury into repair after stroke , 2008, Nature Medicine.